This website is dedicated to providing public information regarding DePuy Hip recall and other related information to the recall. None of the information on this site is intended to be formal legal or medical advice, nor should any information on this site be construed as advice that should be used in lieu of information from your attorney or physician.

Sunday, November 4, 2012

Excluding BHR, Hip Implant growth was flat on last year, which was an
improvement on the last quarter. This compares to total hip market, which was
similarly flat. We continue to achieve very good growth in our product forecast,
such as ANTHOLOGY systems, OXINIUM surface, POLARCUP and SMF system. The
negative commentary on stem metal-on-metal total hip continued and sales of our
BHR system were down by 36%. Finally, the full U.S. launch of our new REDAPT
Revision Hip System, which significantly improves our hip provision product
offering, is on track for later this quarter

(This was one of the last hips that issued a warning to the market on their hip.)